TheEdgeResearch
Home / Stocks / VNNYF

Vinergy Capital Inc. (VNNYF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.15 ▼ -8.96%
Market Cap
$20.6M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.31
52-Wk Range
0.0012-0.2893
CEO
Alnoor Nathoo
Country
CA
Currency
USD

Vinergy Capital Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.15, down 8.96% on the session, giving a market capitalisation of $20.6M. On trailing twelve-month figures it carries a trailing P/E of -10.10, a net margin of -382.9%. Its beta of -0.31 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-10.10
Price / Sales
186.31
Price / Book
13.50
EV / EBITDA
-53.77
Gross margin
100.0%
Operating margin
-350.3%
Net margin
-382.9%
Return on equity
Debt / equity
0.76
Current ratio
0.05
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2017-01-30
Headquarters
Vancouver, BC, CA
About Vinergy Capital Inc.

Vinergy Capital Inc. presently conducts no significant business operations. Established in 2001 and based in Vancouver, Canada, the company underwent a name change in March 2021, transitioning from its former designation as Vinergy Cannabis Capital Inc.

Comparable companies

Vinergy Capital Inc. is most often compared with the following Healthcare names:

ATHJFBFFTFCHBRFGENHGRAMFHDSLFNXTTFOCELTGPHFVILGF
More research on VNNYF
VNNYF technical analysis VNNYF TheEdge Score Compare against peers
Open full interactive analysis & DCF →